ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $142,000 | -22.0% | 3,075 | -58.9% | 0.00% | 0.0% |
Q1 2019 | $182,000 | +34.8% | 7,477 | -21.0% | 0.00% | 0.0% |
Q4 2018 | $135,000 | +15.4% | 9,462 | +22.3% | 0.00% | 0.0% |
Q3 2018 | $117,000 | -16.4% | 7,737 | -10.2% | 0.00% | 0.0% |
Q2 2018 | $140,000 | 0.0% | 8,614 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $140,000 | +164.2% | 8,614 | +107.9% | 0.00% | 0.0% |
Q4 2017 | $53,000 | -11.7% | 4,144 | -13.6% | 0.00% | 0.0% |
Q3 2017 | $60,000 | +42.9% | 4,797 | -5.5% | 0.00% | – |
Q2 2017 | $42,000 | -14.3% | 5,074 | -7.3% | 0.00% | -100.0% |
Q1 2017 | $49,000 | +48.5% | 5,474 | +43.8% | 0.00% | – |
Q4 2016 | $33,000 | +17.9% | 3,806 | -9.5% | 0.00% | – |
Q3 2016 | $28,000 | +100.0% | 4,206 | +6.2% | 0.00% | – |
Q2 2016 | $14,000 | +16.7% | 3,962 | -2.7% | 0.00% | – |
Q1 2016 | $12,000 | -33.3% | 4,072 | -4.0% | 0.00% | – |
Q4 2015 | $18,000 | -10.0% | 4,241 | -4.1% | 0.00% | – |
Q3 2015 | $20,000 | -37.5% | 4,422 | -1.2% | 0.00% | -100.0% |
Q2 2015 | $32,000 | -8.6% | 4,474 | -4.6% | 0.00% | 0.0% |
Q1 2015 | $35,000 | +84.2% | 4,688 | +19.3% | 0.00% | – |
Q4 2014 | $19,000 | +35.7% | 3,928 | +3.7% | 0.00% | – |
Q3 2014 | $14,000 | -17.6% | 3,789 | -0.9% | 0.00% | – |
Q2 2014 | $17,000 | -75.0% | 3,823 | -73.7% | 0.00% | -100.0% |
Q1 2014 | $68,000 | -42.4% | 14,520 | -38.6% | 0.00% | -50.0% |
Q4 2013 | $118,000 | +55.3% | 23,631 | +93.0% | 0.00% | +33.3% |
Q3 2013 | $76,000 | +68.9% | 12,242 | +22.4% | 0.00% | +50.0% |
Q2 2013 | $45,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |